WVE (Wave Pharma) Bozor qiymatining balans qiymatiga nisbati

Wave Life Sciences Ltd. (WVE) - korporativ logo

Wave Life Sciences (WVE) sog'liqni saqlash gigantlari bilan strategik ittifoqlar orqali RNA dori vositalari segmentidagi o'z mavqeini mustahkamlamoqda va dumpingdan himoyalanish uchun noyob oligonucleotidlardan foydalanmoqda. Indikator 1.47 qiymatida qat'iy belgilangan ushbu narxlar grafigi dori vositalarini yetkazib berish paytidagi qat'iy harorat nazorati bo'yicha ma'lumotlar bilan to'ldirilgan. Biznesning rivojlanishi mushak distrofiyasi va Huntington kasalligini davolashdagi yutuqlarga, shuningdek, GSK tomonidan ko'rsatilgan moliyaviy qo'llab-quvvatlashga tayanadi.

wavelifesciences.com (WVE) - Bozor kapitallashuvining balans qiymatiga nisbati 22.08.2022dan 28.10.2026gacha

Wave Life Sciences Ltd (WVE) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Wave Life Sciences|WVE - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Wave Life Sciences Corp|WVE - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Wave Life Sciences|WVE - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati wavelifesciences.com|WVE - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Wave Life Sciences|WVE - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Wave Life Sciences Corp|WVE - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Wave Life Sciences Corp
Kompaniyaning dastlabki tahlili:Wave Life Sciences
Wave Pharma yetakchi tovari

RNA tahrirlash patentlarining qiymati va olimlar bilan tuzilgan sherikliklar Wave Life Sciences (WVE) kompaniyasining sof aktivlar bazasini tashkil etib, uning operatsiyalarining haqiqiy ko'lamini belgilaydi. Ushbu koeffitsient biznesning bozor qiymatini uning balans qiymati bilan solishtiradi, bu esa kompaniyaning P/B koeffitsiyenti baholash tarixi orqali aktivlarning haddan tashqari qimmat baholanganlik darajasini yoki tez-tez uchraydigan tebranishlar davridagi bozor chegirmasini aniqlash imkonini beradi.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati Tempus Labs|QGEN (qiagen.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati Repligen Corp|Bozor kapitallashuvining balans qiymatiga nisbati RNA|Bozor kapitallashuvining balans qiymatiga nisbati CRISPR CRSP|GeneDx Holdings Corp. - Kapitallashuvning sof aktivlarga nisbati|Kapitallashuvning sof aktivlarga nisbati ultragenyx.com RARE|Beam Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Sarepta Therapeutics (SRPT) - Bozor kapitallashuvining balans qiymatiga nisbati|Twist Bio (TWST) - Kapitallashuvning sof aktivlarga nisbati|10x (TXG) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati NTLA (Intellia Therapeutics)|Bozor qiymatining balans qiymatiga koeffitsiyenti stoketherapeutics.com (STOK)|BioLife Solutions (BLFS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati MAZE (Maze Therapeutics, Inc.)|Bozor qiymatining balans qiymatiga nisbati Sionna Pharma SION|Bozor qiymatining balans qiymatiga nisbati Prime Medicine Bio PRME|Bozor kapitallashuvining balans qiymatiga nisbati TSHA (Taysha Gene Therapies)|QURE - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati MeiraGTx (MGTX)|REGENXBIO Inc (RGNX) - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati SLDB (Solid Bio)|Bozor qiymatining balans qiymatiga koeffitsiyenti Ocugen Pharma (OCGN)|Pacific Biosciences (PACB) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati BNTC (benitec.com)|Bozor qiymatining balans qiymatiga nisbati DSGN|Balans qiymatiga nisbatan bozor kapitallashuvi Rocket Pharma RCKT|FDMT: Bozor kapitallashuvining balans qiymatiga nisbati|LXEO - Kapitallashuvning sof aktivlarga nisbati|korrobio.com - Bozor kapitallashuvining balans qiymatiga nisbati|editasmedicine.com (EDIT) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati SLN (Silence Therapeutics plc)|Bozor qiymatining balans qiymatiga koeffitsiyenti PRQR|Bozor qiymatining balans qiymatiga nisbati Codexis, Inc. CDXS|Kapitallashuvning balans qiymatiga nisbati Sangamo BioSciences (SGMO)|Nautilus Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati metagenomi.co MGX|DTIL (Precision BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|GBIO: Bozor qiymatining balans qiymatiga koeffitsiyenti|Boundless Bio, Inc - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Exicure|Kapitallashuvning sof aktivlarga nisbati IMNN|Kapitallashuvning sof aktivlarga nisbati RXi Pharmaceuticals (PHIO)|Kapitallashuvning sof aktivlarga nisbati Mustang Bio, Inc. (MBIO)|Bozor qiymatining balans qiymatiga nisbati transcodetherapeutics.com (RNAZ)|BNGO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Applied DNA Corp APDN|bluebird bio, Inc. (BLUE) - Bozor kapitallashuvining balans qiymatiga nisbati|IPA: Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Omega Therapeutics, Inc.|Singular Genomics Systems, Inc. (OMIC) - Kapitallashuvning balans qiymatiga nisbati|RGLS (Regulus Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Syros Pharmaceuticals, Inc (SYRS)|Kapitallashuvning sof aktivlarga nisbati TBIO (Telesis Bio, Inc.)|Kapitallashuvning sof aktivlarga nisbati traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)